Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Clover Biopharmaceuticals
company
About
Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing vaccines and biologic therapeutic.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥62.80M
- Industries
- Biotechnology,Clinical Trials,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥366.80M
Clover Biopharmaceuticals has raised a total of
¥366.80M
in funding over 2 rounds. Their latest funding was raised on
Nov 27, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 27, 2019 | Series B | ¥304M | 4 | — | — | Detail |
| Dec 14, 2017 | Series A | ¥62.80M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
Clover Biopharmaceuticals is funded by 5 investors.
Tianhe Life Sciences Venture Fund
and Sichuan Province Healthy Pension Industry Equity Investment Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Series B |
|
|
— | Series B |
Zhongguancun VC Development Center
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
